Enavate Sciences GP, LLC

Q2 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    6

  • Value ($000)

    $176,535

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001953107
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
IMNM
IMNM

IMMUNOME INC

COM
45257U108
$44.35M
25 %

4,768,583

---

SIONNA THERAPEUTICS INC

COM
829401108
$42.99M
24 %

2,478,030

---

ZENAS BIOPHARMA INC

COM
98937L105
$36.45M
21 %

3,761,359

---

UPSTREAM BIO INC

COM
91678A107
$27.01M
15 %

2,459,703

CMPX
CMPX

COMPASS THERAPEUTICS INC

COM
20454B104
$20.25M
12 %

7,788,150

---

CAMP4 THERAPEUTICS CORP

COM
13463J101
$5.49M
3 %

3,785,802

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6